Stock EFTR EFFECTOR THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Static Chart eFFECTOR Therapeutics, Inc.

Equities

EFTR

US28202V2079

Real-time Estimate Cboe BZX
Other stock markets
 18:16:53 05/06/2024 BST 		5-day change 1st Jan Change
1.525 USD +7.39% Intraday chart for eFFECTOR Therapeutics, Inc. -9.03% -87.08%
05-20 EFFECTOR Therapeutics to Collaborate with the Dana-Farber Cancer Institute on an Investigator-Sponsored Phase 2 Clinical Trial Evaluating Zotatifin as Combination Treatment in ER+ Endometrial Cancer and in Low Grade Serous Ovarian Cancer CI
05-09 EFFECTOR Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Chart eFFECTOR Therapeutics, Inc.
  1. Stock Market
  2. Equities
  3. EFTR Stock
  4. Charts eFFECTOR Therapeutics, Inc.
  5. Static Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW